Abbott (ABT) RSU sell-vs-hold

Calculator · free · no signup · ABT

Sell at vest or hold? Compare after-tax payout from selling Abbott RSUs at vest vs. holding through the LTCG cliff at 12 months.

AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:Blacklight, August 2026 scan: zero trackersWebbkoll, August 2026 scan: no cookiesMDN HTTP Observatory grade, scanned live

Your vest

pre-IPO? enter price manually

Tax inputs

Hold strategy

1 yr
20%
20%
10.0%

Best after-tax payout — at year 1 yr

$47,709

Sell + invest wins by $4,981 over Hold 1 yr.

Estimates only. Not financial advice.

This vest pushes your top federal rate from 24% to 35%. Hover the Federal value below for the bracket-by-bracket slicing.

Heads-up: under-withholding. Your employer withholds federal tax at the IRS supplemental rate (22.0% on this vest, ≈ $17,600). Your marginal federal rate on this vest is 32.7%, owing $26,171. Expect to settle the $8,571 gap at tax time.

The hidden purchase

Tax was paid at vest either way. Holding is mathematically equivalent to taking $44,509 in after-tax cash and buying $44,509 of ABT today.

Most diversification frameworks would advise against a purchase that size in a single name; the right answer depends on your conviction in ABT. Holding past one year converts the gain to LTCG.

Sell + invest

Best payout
Vest value (shares × price)$80,000
Federal
State
Medicare−$1,160
Additional Medicare−$720
Market gain over 1 yr at 10.0%$4,451
Cap-gain tax on diversified gain — LTCG (federal + state + NIIT)−$1,251
Net at year 1 yr$47,709

Sell every share at vest; invest the after-tax cash at the market return for 1 yr, then liquidate. Diversified — no single-stock concentration risk.

Hold 1 yr

Vest value (shares × price)$80,000
Vest tax (federal + state + FICA)
Net at year 1 yr$42,728

Sold 444 shares to cover vest tax (net-settled); kept 556 shares 1 yr to qualify for long-term capital gains.

Social Security + Medicare are payroll taxes (collectively called FICA) — they apply because you're still employed at vest.

Both columns are stated in year-1 yr dollars. The sell side compounds at the market return; the hold side compounds at your single-stock expected return after a 20% volatility drag.

Estimates only. Assumes net-settled (sell-to-cover) vesting; double-trigger and pre-IPO RSUs are out of scope. Excludes multi-state moves, AMT interactions on other equity, and 83(b) elections. Not financial advice.

You evaluated one RSU vest. The beta plans every vest of every grant across years, with concentration and AMT in the loop.

Request beta access →

Related calculators: RSU Lot Order Calculator · Stock Concentration Calculator

About Abbott

Abbott (ABT) is a public Medical Device company, incorporated in Illinois and headquartered in Abbott Park, IL.

Last close: $98.83 per share (as of 2026-10-01).

Equity grants at Abbott typically include restricted stock units (RSUs).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Source: Wikipedia (CC BY-SA 4.0)

Wallace Calvin Abbott, a Chicago physician, founded Abbott Laboratories in 1888 to produce standardized-dose alkaloidal medicines. The company, now headquartered in Abbott Park, Illinois, makes medical devices, diagnostics, nutrition products, and generic pharmaceuticals, including continuous glucose monitors sold under the FreeStyle Libre brand. In March 2026, Abbott completed its acquisition of Exact Sciences, adding cancer diagnostics to its business; the deal contributed $1.0 billion to Abbott's $12.6 billion in second-quarter 2026 sales, up 13 percent year over year.

Sources: startuptalky.com · bbb.org · benzinga.com · simplywall.st

Equity comp at Abbott

  • RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.

Researched 2026-08-17.

OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Abbott.

Abbott (ABT) RSUs vest as ordinary income at the price on vest day. The decision is whether to sell at vest and reinvest, or hold the shares through the 12-month LTCG cliff. This calculator runs both paths through the same after-tax math so you can compare like-for-like.

Example: 500 Abbott (ABT) RSUs vesting at $98.83 per share is $49,415 of ordinary income on vest day. After roughly 32% combined federal + state + FICA (~$15,813), the post-tax share value is ~$33,602. Holding 12 months for long-term capital-gains treatment then only matters for the price change between vest and sale; the ordinary income at vest is already locked in. The calculator runs both paths through the same after-tax math.

All Abbott tools → · Use the generic RSU Sell-vs-Hold Calculator for any company. Diversifying multiple RSU lots? See the lot-by-lot sell order →

Abbott equity questions

Should I sell or hold my Abbott RSUs at vest?
Abbott restricted stock units (RSUs) are taxed as ordinary income on their value at vest whether or not you sell. The only open decision is what to do with the shares afterward: sell at vest and reinvest, or hold past twelve months for long-term capital-gains treatment on any further gain. The calculator above runs both paths through the same after-tax math so you can compare them directly.
Does Abbott grant ISOs, NSOs, or RSUs?
Equity compensation at Abbott typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
Do Abbott RSUs use double-trigger vesting?
No. Abbott restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyMedical Devices peers

One piece of the puzzle.

OptionsAhoy plans your Abbott equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.

Request beta access